METABOLISM OF ADJACENT ADIPOSE TISSUE AND BODY MASS OF THE PATIENTS WITH STAGE III–IV COLORECTAL CANCER

Authors

  • A.P. Burlaka R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
  • A.V. Vovk R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
  • A.A. Burlaka National Cancer Institute, MH of Ukraine, Kyiv, Ukraine
  • V.V. Zvirych National Cancer Institute, MH of Ukraine, Kyiv, Ukraine
  • S.M. Lukin R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
  • S.V. Virko R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine

Keywords:

colorectal cancer, obesity, metastasis, nitric oxide, superoxide radicals, free fatty acids.

Abstract

Summary. Obesity is a pathological accumulation of hypertrophied adipocytes, which may be an unfavorable
factor in the formation of tumor cell chemo-resistance
and the progression of malignant neoplasms (local relapses, metastases). A critical molecule that influences the growth and metastasis of tumors is nitric oxide
ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ
ОНКОЛОГИЯ • Т. 20 • № 3 • 2018 211 211
(NO), which can damage DNA, suppress the DNA repair enzymes, regulate apoptosis and metastasize. Proliferation of tumor cells, angiogenesis, metastases are
closely related to the functioning of NO and superoxide
radicals (SR). Objective: to investigate the levels of NO
and SR in adjacent adipose tissue (AAT), as well as the
concentration of free (un-esterified) fatty acids (FFA)
in the blood of patients with colorectal cancer (CC) stage
III–IV, depending on the weight of the patient’s body,
degree tumor differentiation, volume of metastases (M)
in the liver. Object and methods: samples of AATs of patients with CC of the III–IV stage with obesity (body
mass index (BMI) > 25; n = 84) and without its signs
(BMI < 25; n = 47). For control (normal adipose tissue — NAT) considered the material from 18 patients
with benign neoplasms. The rate of generation of SR by
mitochondria and the NO level in the samples of the
adipose tissue were determined by the method of electron paramagnetic resonance (EPR) at room temperature and at low temperature using appropriate spin
traps. The content of FFA in blood was determined by
spectrophotometric method at λ = 546 nm. Results: the
activity of FeS-proteins of the electron transport chain
(ETC) of mitochondria in the AATs of patients with CC
(BMI > 25) was significantly higher compared to that
in NAT; the level of ubisemichinon in AAT was 11 times
higher than that of NAT. An increase in the level of activity of molybdenum-containing enzymes (xanthine and
aldehyde oxidase) was also observed in AATs of patients
with CC, indicating accumulation of toxic products of
decomposition of purines and aldehydes in it. The level
of SR in AAT patients with CC with BMI > 25 was 5.6
and 1.3 times higher than in the NAT and in patients
without obesity (BMI 18.5–25), respectively. The level
of NO in AAT patients with BMI > 25 was significantly
lower in comparison with NAT, in AAT of patients without obesity did not differ from such in NAT (p > 0.05).
The level of FFA in the blood of patients with CC, regardless of the presence of signs of obesity (with BMI
18.5–25 and > 25), exceeded this indicator in donors
(BMI >25) by 3.4 and 6.0 times, respectively (p<0.05).
In the adipose tissue, adjacent to the G1–2- and G3-
tumors, NO levels were significantly different, however, they were lower in 2.0 and 2.5 times than in NAT
(p < 0.05). In patients with morbid obesity (BMI > 40)
the average volume of M was 19.75 ± 5.9 cm3
. Volume
M was significantly lower in patients with BMI < 40: at
BMI 18.5–24.9 was 4.33 ± 2.6 cm3
, with BMT 25–
40 — 8.40 ± 3.7 cm3
. Conclusions: the severity and direction of changes in a number of characteristics of the
adipose tissue of patients with CC of III–IV stage (spectra of AAT EPR, NO and SR levels in AAT compared
with NAT, the concentration of FFA in blood) has an
indisputable link with the weight of patients: in the presence of different degrees of obesity metabolic disorders
increase. In patients with morbid obesity, the largest
volume of M in the liver was observed. Based on the
results obtained, selective NO-dependent regulation of
ETC in mitochondria, in particular, in AAT, to influence energy expenditure can be an effective component
in the strategy of treatment of patients with CC.

References

Berger NA. Young Adult Cancer: Influence of the Obesity Pandemic. Obesity 2018; 26 (4): 641–50.

O’Rourke RW. Obesity and cancer: at the crossroads of cellular metabolism and proliferation. Surg Obes Relat Dis 2014; 10 (6): 1208–19.

Schwartz В, Yehuda-Shnaidman E. Putative role of adipose tissue in growth and metabolism of colon cancer cells. Front Oncol 2014; 4: 164.

Marseglia L, Manti S, D’Angelo G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci 2015; 16 (1): 378–400.

Nieman KM, Romero IL, Van Houten B, et al. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 2013; 1831 (10): 1533–41.

Burlaka AP, Vovk AV, Ganusevich II, et al. Superoxide- and NO-dependent mechanisms of formation of metastatic microenvironment distant sites of metastasis in patients with colorectal cancer. Oncology 2017; 19: 64–70 (in Ukrainian).

Cheng H, Wang L, Mollica M, et al. Nitric oxide in cancer metastasis. Cancer Lett. 2014; 353 (1): 1–7.

Burlaka AP, Sidorik EP. Redox-dependent signal molecules in mechanisms of tumor process. Kyiv: Naukova Dumka, 2014. 255 p. (in Ukrainian).

Pérez S, Taléns-Visconti R, Rius-Pérez S, et al. Redox signaling in the gastrointestinal tract. Free Radic Biol Med 2017;

: 75–103.

Sansbury BE, Hill BG. Regulation of obesity and insulin resistance by nitric oxide. Free Radic Biol Med 2014; 73: 383–99.

Fukumura D, Incio J, Shankaraiah RC et al. Obesity and cancer: an angiogenic and inflammatory link. Microcirculation 2016; 23 (3): 191–206.

BMI Classification. Global Database on Body Mass Index. World Health Organization 2006; 27: 2012.

Burlaka АP, Ganusevich ІІ, Golotiuk VV, et al. Superoxide- and NO-dependent mechanisms of antitumor and antimetastatic effect of L-arginine hydrochloride and coemzyme Q10. Exp Oncol 2016; 38: 31–5.

Smith SR, Wilson PW. Free fatty acids and atherosclerosis. J Clin Endocrinol Metab 2006; 91: 2506–8.

Rizi BS, Achreja A, Nagrath D. Nitric oxide: the forgotten child of tumor metabolism. Trends Cancer 2017; 3 (9): 659–72.

da Costa RM, Fais RS, Dechandt CR, et al. Increased mitochondrial ROS generation mediates the loss of the anti-contractile effects of perivascular adipose tissue in high-fat diet obese mice. Br J Pharmacol 2017; 174 (20): 3527–41.

Harmey JH, Bucana CD, Lu W, et al. Lipopolysaccharideinduced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int J Cancer 2002; 101: 415–22.

Ortega ÁL, Mena S, Estrela JM. Oxidative and nitrosative stress in the metastatic microenvironment. Cancers 2010; 2:

–304.

Panieri E, Santoro MM. ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death and Disease

; 7: e2253.

Saha SK, Lee SB, Won J, et al. Correlation between oxidative stress, nutrition, and cancer initiation. Int J Mol Sci 2017;

: 1544–57.

Kwan HY, Chao X, Su T, et al. Dietary lipids and adipocytes: potential therapeutic targets in cancers. J Nutr Biochem

; 26 (4): 303–11.

Xia N, Forstermann U, Li H. Effects of resveratrol on eNOS in the endothelium and the perivascular adipose tissue. Ann NY Acad Sci 2017; 1403: 132–41.

Kang YM, Kim F, Lee WJ. Role of NO/VASP signaling pathway against obesity-related inflammation and insulin resistance. Diabetes Metab J 2017; 41: 89–95.

Melnyk І, Korourian І, Levy JW, et al. Effects of obesity on pro-oxidative conditions and DNA damage in liver of

DMBA-induced mammary carcinogenesis models. Metabolites 2017; 7 (26).

Burlaka AP, Ganusevich II, Vovk AV, et al. The redox-state of adipose tissue: effect on the microenvironment and progression of gastric cancer. Oncology 2017; 19 (2): 118–24 (in Ukrainian).

Lin J, Chuang C, Zuo L. Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets. Oncotarget 2017; 8 (10): 17328–46.

He J, Jiang BH. Interplay between reactive oxygen species and microRNAs in cancer. Curr Pharmacol Rep 2016; 2(2): 82–90.

Published

2018-10-08

How to Cite

Burlaka, A., Vovk, A., Burlaka, A., Zvirych, V., Lukin, S., & Virko, S. (2018). METABOLISM OF ADJACENT ADIPOSE TISSUE AND BODY MASS OF THE PATIENTS WITH STAGE III–IV COLORECTAL CANCER. Oncology, 20(3), 206–211. Retrieved from https://nasu-periodicals.org.ua/index.php/oncology/article/view/27258

Issue

Section

Original investigations